NCT01953926 2024-03-12
SUMMIT
Puma Biotechnology, Inc.
Phase 2 Terminated
Puma Biotechnology, Inc.
Intergroupe Francophone de Cancerologie Thoracique
Fondazione per la Medicina Personalizzata
National Cancer Institute (NCI)
Istituto Clinico Humanitas